Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

NCT07062627 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma (PCNSL)
Diffuse Large B Cell Lymphoma (DLBCL)

Interventions

GENETIC: Anbal-cel

Sponsor

Hyungwoo Cho

Collaborators

[object Object]